Tue, Jul 7, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Jury selection starts at Matthew Martoma’s trial

Wednesday, January 08, 2014

Komfie Manalo, Opalesque Asia:

Prosecution and defense lawyers began the tedious task of jury selection Tuesday in the trial of former SAC Capital Advisors portfolio manager Matthew Martoma who is charged with engaging the most lucrative inside trading scheme in the U.S. financial history.

According to City AM US District Judge Paul Gardephe told the 80 potential jurors to keep an open mind and steer clear of media reports while they are being considered as a juror.

The potential candidates were given questionnaires to determine if they are suited to act as jury during the trial which is expected to last more than three weeks. The trial of Martoma has generated so much interest in New York because of the high profile people and firms it involved.

A Reuters report said the jurors were asked of their knowledge about Martoma and how much information from the media have they read or heard of Cohen and SAC Capital.

One juror wrote in the questionnaire that Martoma was involved "an unsavory and corrupt industry." That juror was excused by Gardephe along with another potential juror who voiced out "political bias against Wall Street, its practices and its excessive greed." After Tuesday’s questioning, 26 potential jurors were excused by the judge a......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Opalesque Exclusive: New systematic strategy managed alongside research firm outperforms S&P500[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: An emerging CTA manager explains how he runs his strategy, which is based on an index produced by a research firm. Peter Turk is head of

  2. Opalesque Exclusive: New systematic strategy embraces machine learning[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: The founder of a New York-based systematic trading firm, which offers a hybrid between alpha strategies and alternative feta at lower fees, describes his approa

  3. Larry Robbins' hedge fund Glenview buys 1m Tenet Healthcare shares[more]

    Komfie Manalo, Opalesque Asia: Glenview Capital Management said it bought an additional 979,482 shares at Tenet Healthcare Corp valued at $53.80 million, raising its stakes in the healthcare services company to 15.16%, reported

  4. Legal - Grayson’s hedge funds under scrutiny for possible ethics violations, Court rejects hedge fund’s motion to block merger of Samsung affiliates[more]

    Grayson’s hedge funds under scrutiny for possible ethics violations From Freebeacon.com: Rep. Alan Grayson is finding himself in hot water over managing hedge funds that bear his name, actions that are in possible violation of House ethics rules. Sitting members of Congress are prohibite

  5. Hedge funds decline in June as stocks tumble on Greek woes[more]

    From Bloomberg.com: Hedge funds posted losses across strategies last month as uncertainty over whether Greece will remain in the euro sent global stock markets tumbling. Winton Capital Management declined about 3.1 percent in June in its $12.1 billion Winton Futures Fund, leaving it down 1.9 percent

 

banner